The CNIB Foundation has signed a new partnership agreement with IrisVision, global
leader in digital vision technologies.
IrisVision’s visual assistive device allows users to access
and amplify their limited sight. The wearable device is FDA registered, and
helps users with a variety of eye conditions including age-related macular
degeneration, Stargart disease, and glaucoma.
“IrisVision redefines possibilities for those living with vision
impairment and aims to not only provide sight, but to connect people with their
world,” says Ammad Khan, CEO of IrisVision. “We are proud to be partnering
with the CNIB Foundation, an organization that supports Canadians with sight
loss from coast to coast. We’ve had thousands of success stories in the United
States and are looking forward to expanding our resources to the 1.5 million
Canadians living with low vision.”
Through this partnership, people with sight loss across the country will
have exclusive access to IrisVision’s products as soon as they launch through
all of the CNIB Foundation’s enterprises, including Shop CNIB, CNIB Frontier
Accessibility and its affiliate organization, Vision Loss Rehabilitation
Canada.
Click HERE for the full press release.